Respiratory proteomics: from descriptive studies to personalized medicine.
Respiratory diseases are highly prevalent and affect humankind worldwide, causing extensive morbidity and mortality with the environment playing an important role. Given the complex structure of the airways, sophisticated tools are required for early diagnosis; initial symptoms are nonspecific, and the clinical diagnosis is made frequently late. Over the past few years, proteomics has made high technological progress in mass-spectrometry-based protein identification and has allowed us to gain new insights into disease mechanisms and identify potential novel therapeutic targets. This review will highlight the contributions of proteomics toward the understanding of the respiratory proteome listing potential biomarkers and its potential application to the clinic. We also outline the contributions of proteomics to creating a personalized approach in respiratory medicine.
Instituto Nacional de Enfermedades Respiratorias , Calz. de Tlalpan 4502, Distrito Federal 14080, Mexico.
Luis M
LM
Teran
Rosalia
R
Montes-Vizuet
Xinping
X
Li
Thomas
T
Franz
D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D006801:Humans; D008171:Lung Diseases / Q000378:metabolism* / Q000628:therapy; D057285:Precision Medicine; D020543:Proteome / Q000378:metabolism*; D040901:Proteomics; D012220:Rhinitis / Q000378:metabolism / Q000628:therapy
D015415:Biomarkers; D020543:Proteome
AERD; COPD; allergic rhinitis; asthma; environment; mass spectrometry; personalized medicine; protein biomarkers; respiratory diseases; respiratory proteomics